Complain about a product or service

FDA, FTC Warn Web Sites on Fake Swine Flu Supplements

Bogus products could be dangerous

By James Limbach
ConsumerAffairs.com

October 20, 2009

• Three More Cases Of Swine Flu In Pets • FDA Expands Approved Use Of Swine Flu Vaccines To Include Infants And Children • CDC Ups Swine Flu Death Estimate To 4,000 • Iowa Cat Diagnosed with Swine Flu • Swine Flu Vaccine Not Keeping Pace With Demand • Word Is Out On Unapproved Swine Flu Products • Swine Flu Virus Found In Pig Sample • FDA Warns Of Internet Sales Of Swine Flu Drug Products • Gauge Swine Flu Symptoms With Online Tool • H1N1 Flu Spreading Rapidly Through U.S. • Preparing For Flu Season • FDA Approves Vaccines For Swine Flu • Video: Swine Flu Vaccine Running Behind Schedule • New iPhone App Locates Swine Flu, Infectious Diseases • CDC Makes Recommendations For Use Of Swine Flu Vaccine • FDA Authorizes Emergency Use Of Another Test For Swine Flu Virus • Experts Worry About Return Of Swine Flu • CDC Finds Swine Flu Still Hanging Around • Swine Flu Officially a Pandemic • CDC: Swine Flu May Have Peaked • Older People Appear More Resistant To Swine Flu • Swine Flu Claims Sixth U.S. Victim • Poll Finds Americans Concerned About Swine Flu • CDC Sees 'Encouraging' Swine Flu Signs • Swine Flu Spreads, But Relatively Few Deaths Reported • What to Do If You Get Flu-Like Symptoms • Swine Flu a Potential Problem for Cruise Ships • Swine Flu Spreads, As Do Scams • Swine Flu Tips for Child Care Providers • More Warnings Against Swine Flu Scams • Can the Right Mask Prevent Swine Flu? • No Reason To Panic Over Swine Flu • Watch Out For Swine Flu Scams • Swine Flu: What You Need to Know • HHS Declares Public Health Emergency for Swine Flu

The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have issued a joint warning letter to a Web site marketing fraudulent supplements that claim to help prevent the spread of the swine, or 2009 H1N1, flu virus.

The warning letter, the first to be issued jointly by the agencies, advises the owners of the site that they must discontinue the fraudulent marketing of their product or face legal action. It further advises the owners of the site that they have 48 hours to give the agencies a plan to discontinue their fraudulent marketing.

The FDA and the FTC remind consumers to be cautious of promotions or Internet sites offering products for sale that claim to diagnose, prevent, mitigate, treat or cure the virus. Fraudulent swine flu products come in many varieties, including dietary supplements, as well as products purporting to be drugs, medical devices or vaccines. Since May 2009, the FDA has warned more than 75 Web sites to stop the sale of more than 135 products with fraudulent H1N1 influenza virus claims.

"Products that are offered for sale with claims to diagnose, prevent, mitigate, treat or cure the 2009 H1N1 influenza virus must be carefully evaluated," said Commissioner of Food and Drugs Margaret A. Hamburg, M.D. "Unless these products are proven to be safe and effective for the claims that are made, it is not known whether they will prevent the transmission of the virus or offer effective remedies against infection. Furthermore, they can make matters worse by providing consumers with a false sense of protection."

The agencies also warn consumers to take extreme care when buying products over the Internet that claim to diagnose, prevent, treat or cure the swine flu virus because, in addition to being fraudulent, they could be dangerous.

In collaboration with the FTC, the FDA will continue to work aggressively to identify, investigate and take regulatory action against individuals or businesses that wrongfully promote purported 2009 H1N1 influenza products.

This will include taking joint action, when appropriate, such as the issuance of the joint warning letter. Additional legal action could include an injunction or issuance of an administrative order by the FTC or seizure of products, an injunction or criminal prosecution by the FDA.

"The FDA continues to consider the sale and promotion of fraudulent H1N1 influenza products to be a possible threat to the public health and in violation of the Federal Food Drug and Cosmetic Act," said Michael Chappell, acting associate commissioner for regulatory affairs. "The FDA has an aggressive surveillance program to detect fraudulent H1N1-related products and will take prompt action to stop the marketing of fraudulent H1N1 influenza products and will hold those who are responsible for doing so accountable."

There are two antiviral drugs approved by the FDA for treatment and prophylaxis of the 2009 H1N1 influenza virus -- Tamiflu (oseltamivir phosphate) and Relenza (zanamivir). Tamiflu and Relenza, in addition to their approved labeling, have been issued Emergency Use Authorizations by the FDA that describe specific authorized uses during this public health emergency.

Consumers are urged to report any suspected fraudulent products or criminal activity relating to FDA-regulated products associated with swine flu virus, including the names of Web sites that may be offering these products for sale, to the FDA by visiting: FDA.

Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.

Share		Follow us on Twitter.